Income for the quarter stood at Rs 6,164 crore, up from Rs 5,514 crore a 12 months in the past.
“We proceed to construct robust enterprise momentum, anchored by a strong product portfolio, improved efficiencies, and efficient use of property and investments,” stated Nilesh Gupta, Managing Director, Lupin.
“As we start the 12 months, our sharpened give attention to compliance, innovation, and expertise positions us to additional unlock sustainable progress,” he added.
The corporate reported US gross sales of Rs 2,404 crore within the June quarter, registering a 24% progress in comparison with Rs 1,934 crore within the year-ago interval.
Must you purchase, promote, or maintain Lupin inventory? Right here’s what brokerages say:
Alternative Broking
Alternative upgraded its ranking on Lupin to ‘Purchase’ and raised the goal worth to Rs 2,375 (from Rs 2,270), citing continued progress momentum throughout key markets, particularly North America and India. Excessive-impact launches corresponding to Liraglutide and Glucagon are anticipated to contribute considerably to income.
Whereas margins might face momentary strain in FY26 as a consequence of elevated R&D spend on the GLP-1 portfolio, the agency expects normalisation by FY27 as scale advantages kick in.
Alternative forecasts a income, EBITDA, and PAT CAGR of 12%, 14%, and 12%, respectively, over FY25–28E. The inventory is valued at 25x FY27–28E common EPS.
Motilal Oswal (MOSL)
Motilal Oswal maintained a ‘Impartial’ stance on Lupin and revised its goal worth downward to Rs 2,000 (from Rs 2,140). Whereas acknowledging the earnings shock pushed by robust US execution, MOSL highlighted restricted upside from present ranges.
It raised earnings estimates by 5.5% for FY26 and a couple of% for FY27. The inventory is at the moment valued at 22x 12-month ahead earnings, with EBITDA and PAT CAGRs of 14% and 16%, respectively, over FY25–27.
It expects EBITDA margins of 24–25% in FY26.
(Disclaimer: Suggestions, recommendations, views and opinions given by the consultants are their very own. These don’t symbolize the views of the Financial Occasions)
